eb-101
eb-101: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: ABEONA THERAPEUTICS INC. (ABEO)
Development Pipeline (1)
| Company | Phase |
|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | — |
Clinical Trials (1)
A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Frequently asked questions
Who is developing eb-101?
eb-101 is being developed by ABEONA THERAPEUTICS INC..
How many clinical trials involve eb-101?
BioSniper tracks 1 clinical trial involving eb-101.
Analyze ABEONA THERAPEUTICS INC. & eb-101 with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company